Session Information
-
WCLC 2017
18th World Conference on Lung Cancer
Conference Program for the 18th World Conference on Lung Cancer in Yokohama, Japan
Download PDF of the Conference Program: Click Here.
Onsite Conference Program Addendum (17/10/2017): Click Here.
Download PDF of the Abstract Book: Click Here.
Financial Disclosure Summary (PDF): Click Here.Presentation Date(s):- Oct 15 - 18, 2017
- Total Presentations: 2295
October 14 Sat
Oct 14 Sunday
October 15 Sun
Oct 15 Monday
October 16 Mon
Oct 16 Tuesday
October 17 Tue
Oct 17 Wednesday
October 18 Wed
Oct 18
-
+
P2.04 - Clinical Design, Statistics and Clinical Trials
- 09:30 - 16:00
- 10/17/2017
- Location: Exhibit Hall (Hall B + C)
- Type: Poster Session with Presenters Present
- Track: Clinical Design, Statistics and Clinical Trials
-
+
P2.04-003 - Phase II Trial of X-396 (Ensartinib) for Chinese Patients with ALK (+) Non–Small-Cell Lung Cancer Who Progressed on Crizotinib
09:30 - 09:30 | Presenter: Li Zhang | Author(s): Junling Li, W. Zhong, Y. Hu, X. Liu, Z. Wang, Y. Zhao, J. Feng, J. Zhou, Y. Zhang, Yun Fan, G. Wu, F. Tan, L. Ding
- Abstract
Loading... -
+
P2.04-012 - First-Line Ensartinib (X396) versus Crizotinib in Advanced ALK-Rearranged NSCLC (eXalt3): A Randomized, Open-Label, Phase 3 Study
09:30 - 09:30 | Presenter: Yi-Long Wu | Author(s): Tony SK Mok, Martin Reck, Heather A Wakelee, C. Liang, F. Tan, K. Harrow, V. Oertel, G. Dukart, L. Ding, L. Horn
- Abstract
Loading...